Haemonetics (HAE) Cash from Investing Activities (2009 - 2026)
Haemonetics (HAE) posted quarterly Cash from Investing Activities of -$86.6 million for Q1 2026, down 580.12% year-over-year from $18.0 million in Q1 2025, and down 193.94% quarter-over-quarter from -$29.5 million in Q4 2025.
Haemonetics (HAE) Cash from Investing Activities (2009 - 2026) Analysis & Trends
Haemonetics' Cash from Investing Activities history runs 18 years deep, the most recent figure standing at -$86.6 million for Q1 2026.
- In Q1 2026, Cash from Investing Activities fell 580.12% year-over-year to -$86.6 million; the TTM figure through Mar 2026 stood at -$179.5 million (down 10.9% YoY), while the FY2026 annual figure was -$179.5 million, down 10.9% from the prior year.
- Cash from Investing Activities for Q1 2026 stood at -$86.6 million, down from -$29.5 million in the prior quarter.
- The five-year high for Cash from Investing Activities was $18.0 million in Q1 2025, with the low at -$268.9 million in Q4 2023.
- The 5-year median for Cash from Investing Activities is -$30.0 million (2025), against an average of -$47.6 million.
- The sharpest annual moves came in 2024 and 2025: Cash from Investing Activities plunged 812.11% in 2024, then jumped 238.17% in 2025.
- Haemonetics' Cash from Investing Activities stood at -$36.5 million in 2022, then sank by 636.81% to -$268.9 million in 2023, then surged by 93.54% to -$17.4 million in 2024, then plunged by 69.63% to -$29.5 million in 2025, then plunged by 193.94% to -$86.6 million in 2026.
- Business Quant data shows HAE's Cash from Investing Activities at -$86.6 million in Q1 2026, -$29.5 million in Q4 2025, and -$30.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.70 Bn | 194.09 Bn | 7.27 Bn | -673.00 Mn |
| 2 | Stryker | 129.93 Bn | 126.46 Bn | 4.50 Bn | -639.00 Mn |
| 3 | Medtronic | 120.49 Bn | 111.27 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 74.60 Bn | 74.06 Bn | 3.85 Bn | -1.96 Bn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.42 Bn | 1.35 Bn | -193.20 Mn |
| 6 | Dexcom | 34.78 Bn | 32.84 Bn | 830.00 Mn | 329.80 Mn |
| 7 | GE HealthCare Technologies | 33.83 Bn | 31.72 Bn | 2.18 Bn | -115.00 Mn |
| 8 | Koninklijke Philips | 26.44 Bn | 23.12 Bn | 4.55 Bn | -22.08 Mn |
| 9 | Steris | 23.18 Bn | 22.69 Bn | 684.20 Mn | -108.50 Mn |
| 10 | Haemonetics | 4.93 Bn | 4.70 Bn | 202.80 Mn | -22.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | -22.23 Mn |
| Jun 27, 2026 | -22.23 Mn |
| Mar 28, 2026 | -86.61 Mn |
| Mar 28, 2026 | -86.61 Mn |
| Dec 27, 2025 | -29.47 Mn |
| Dec 27, 2025 | -29.47 Mn |
| Sep 27, 2025 | -30.47 Mn |
| Sep 27, 2025 | -30.47 Mn |
| Jun 28, 2025 | -33.00 Mn |
| Jun 28, 2025 | -33.00 Mn |
| Mar 29, 2025 | 18.04 Mn |
| Mar 29, 2025 | 18.04 Mn |
| Dec 28, 2024 | -17.37 Mn |
| Dec 28, 2024 | -17.37 Mn |
| Sep 28, 2024 | -23.37 Mn |
| Sep 28, 2024 | -23.37 Mn |
| Jun 29, 2024 | -139.20 Mn |
| Jun 29, 2024 | -139.20 Mn |
| Mar 30, 2024 | -13.06 Mn |
| Mar 30, 2024 | -13.06 Mn |